Baker Ellis Asset Management LLC Pfizer Inc Transaction History

Baker Ellis Asset Management LLC

$661 Million
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 23, 2024	SELL	$26.13 - $33.94 $60,882 - $79,080	-2,330 Reduced 23.23%	7,702 $221,000
Q3 2023 Oct 24, 2023	SELL	$32.09 - $37.51 $67,389 - $78,771	-2,100 Reduced 17.31%	10,032 $332,000
Q2 2023 Aug 09, 2023	BUY	$36.12 - $41.79 $29,835 - $34,518	826 Added 7.31%	12,132 $445,000
Q1 2023 May 08, 2023	SELL	$39.39 - $51.28 $24,815 - $32,306	-630 Reduced 5.28%	11,306 $461,000
Q4 2022 Feb 09, 2023	SELL	$41.75 - $54.5 $14,946 - $19,511	-358 Reduced 2.91%	11,936 $611,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $35,008 - $42,736	800 Added 6.96%	12,294 $538,000
Q2 2022 Jul 22, 2022	BUY	$46.53 - $55.17 $14,517 - $17,213	312 Added 2.79%	11,494 $603,000
Q4 2021 Jan 27, 2022	BUY	$41.32 - $61.25 $17,189 - $25,480	416 Added 3.86%	11,182 $660,000
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $5,386 - $6,102	150 Added 1.41%	10,766 $422,000
Q1 2021 Apr 28, 2021	BUY	$33.49 - $37.77 $4,588 - $5,174	137 Added 1.31%	10,616 $385,000
Q4 2020 Feb 04, 2021	SELL	$33.47 - $42.56 $10,041 - $12,768	-300 Reduced 2.78%	10,479 $386,000
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $4,762 - $5,587	-150 Reduced 1.37%	10,779 $396,000
Q1 2020 May 12, 2020	SELL	$27.03 - $38.62 $35,139 - $50,206	-1,300 Reduced 10.63%	10,929 $357,000
Q4 2019 Feb 10, 2020	SELL	$32.92 - $37.36 $357,182 - $405,356	-10,850 Reduced 47.01%	12,229 $479,000
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $8,122 - $10,532	-250 Reduced 1.07%	23,079 $829,000
Q2 2019 Aug 12, 2019	SELL	$36.98 - $41.52 $22,187 - $24,912	-600 Reduced 2.51%	23,329 $1.01 Million
Q1 2019 May 09, 2019	SELL	$37.5 - $41.2 $32,362 - $35,555	-863 Reduced 3.48%	23,929 $1.02 Million
Q4 2018 Feb 07, 2019	SELL	$38.47 - $43.86 $30,776 - $35,088	-800 Reduced 3.13%	24,792 $1.08 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $359,728 - $436,329	-10,436 Reduced 28.97%	25,592 $1.13 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $92,838 - $98,975	-2,815 Reduced 7.25%	36,028 $1.31 Million
Q1 2018 Apr 19, 2018	SELL	$31.91 - $37.02 $12,764 - $14,808	-400 Reduced 1.02%	38,843 $1.38 Million
Q4 2017 Jan 30, 2018	SELL	$33.26 - $35.29 $29,934 - $31,761	-900 Reduced 2.24%	39,243 $1.42 Million
Q3 2017 Oct 18, 2017	BUY	$31.0 - $34.15 $1.24 Million - $1.37 Million	40,143	40,143 $1.43 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$15.2 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$12.6 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$8.51 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.93 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

117M
Shares

$3.48 Billion
0.63% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Ellis Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baker Ellis Asset Management LLC with notifications on news.

Account